You have 9 free searches left this month | to do more

abemaciclib

Abemaciclib is a drug used to treat Breast Cancer, Advanced Cancer, Neoplasm Metastasis, and other conditions. Abemaciclib is being actively studied in 93 studies and prior, has been studied in 22.

Top SponsorsTop SitesTop Investigators
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterZahi Mitri, MD, MS
Dana-Farber Cancer InstituteFor additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.Amy Tiersten
National Cancer Institute (NCI)Hospital Universitario Ramon y CajalAnita Turk
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Recruiting
  • Breast Cancer
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-12-13
Dec 13, 2021
D
Active, not recruiting
  • Breast Cancer
  • Abemaciclib
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
2022-02-15
Feb 15, 2022
S
Recruiting
  • Thyroid Cancer
  • +2 more
  • Abemaciclib
  • Stanford, California
    Stanford University
2022-03-25
Mar 25, 2022
U
Recruiting
  • HNSCC
  • Abemaciclib
  • Tucson, Arizona
    University of Arizona
2022-03-03
Mar 3, 2022
D
Withdrawn
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
2021-12-13
Dec 13, 2021
M
Active, not recruiting
  • Sarcoma
  • Dedifferentiated Liposarcoma
  • Abemaciclib
  • New York, New York
    Memorial Sloan Kettering Cancer Center
2021-08-17
Aug 17, 2021
N
Recruiting
  • Neurofibromatosis 1
  • Abemaciclib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Kaposi Sarcoma
  • Abemaciclib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
C
Not yet recruiting
  • Breast Cancer
  • (no location specified)
2022-02-18
Feb 18, 2022
M
Recruiting
  • Solid Tumor
  • Advanced Breast Cancer
  • Abemaciclib
  • +6 more
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
2021-10-26
Oct 26, 2021
D
Recruiting
  • Prostate Cancer
  • Metastatic Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
2021-09-20
Sep 20, 2021
S
Recruiting
  • Advanced Dedifferentiated Liposarcoma
  • Abemaciclib
  • Placebo
  • Boston, Massachusetts
  • +3 more
2022-03-01
Mar 1, 2022
U
Active, not recruiting
  • GBM
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
2022-01-23
Jan 23, 2022
H
Recruiting
  • Brain Metastases
  • HR+ Metastatic Breast Cancer
  • Stereotactic Radiosurgery (SRS)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
2022-03-03
Mar 3, 2022
A
Active, not recruiting
  • Hepatocellular Carcinoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
2021-08-05
Aug 5, 2021
B
Active, not recruiting
  • Renal Cell Carcinoma Metastatic
  • Hershey, Pennsylvania
    Penn State Cancer Institute
2022-01-05
Jan 5, 2022
U
Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +6 more
  • Abemaciclib
  • Lutetium Lu 177-PSMA-617
  • San Francisco, California
    University of California, San Francisco
2022-02-01
Feb 1, 2022
E
Completed
  • Advanced Cancer
  • Abemaciclib
  • +2 more
  • Kashiwa, Chiba, Japan
  • +1 more
2021-09-20
Sep 20, 2021
I
Recruiting
  • Breast Cancer
  • Metastasis
  • New York, New York
  • +2 more
2021-10-14
Oct 14, 2021
B
Not yet recruiting
  • Metastatic Esophageal Adenocarcinoma
  • Metastatic Gastroesophageal Junction Adenocarcinoma
  • Dallas, Texas
    Baylor University Medical Center, Charles A Sammons Cancer Cente
2021-06-04
Jun 4, 2021
M
Active, not recruiting
  • Brain Tumor
  • abemaciclib
  • Hartford, Connecticut
  • +7 more
2022-03-30
Mar 30, 2022
C
Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +3 more
  • Abemaciclib
  • Questionnaire Administration
  • Duarte, California
    City of Hope Medical Center
2022-03-07
Mar 7, 2022
N
Recruiting
  • Glioblastoma
  • +2 more
  • Chandler, Arizona
  • +2 more
2022-03-10
Mar 10, 2022